Linked research, clinical, and regulatory source pathways.
Company profile
About Radformation
Radformation is a healthcare technology company specializing in intelligent automation software for radiation oncology. Founded in 2016 by a team of clinical physicists, the company develops solutions that streamline the entire cancer treatment planning workflow—from contouring and planning to evaluation, treatment monitoring, and billing QA. Their comprehensive product suite includes AutoContour for automated AI contouring with 480+ structure models, EZFluence and OptiPlan for automated 3D and VMAT planning, ClearCheck and ClearCalc for plan evaluation and independent calculations, ChartCheck for automated treatment evaluation and adaptive assessment, RadMachine for comprehensive machine QA, and QuickCode for billing QA. The company's mission is to make high-quality cancer care accessible everywhere by automating and standardizing treatment planning workflows. Radformation's tools are designed to be user-friendly, clinically relevant, and integrate seamlessly with Eclipse TPS. Used daily in thousands of clinics worldwide, their software helps reduce errors, increase efficiency, and enable cancer clinics to support higher patient throughput while maintaining the highest standards of care. The company is headquartered in New York and has grown to over 200 team members, serving more than 2,000 clinic installations globally including international markets.
Company description Radformation official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cancer
- Radiation Oncology
Who it serves
- Cancer Clinics
- Health Systems
- Radiation Oncology Departments
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Eclipse TPS.
Geographic context
Company milestones
Platform expansion
Acquired Limbus AI in 2024. Reached 2,000 clinic installations in 2024. Grew to 200 team members in 2025. Launched ChartCheck Adaptive in 2025. Launched RadMonteCarlo in 2022. Launched RadMachine in 2022.
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Cone Beam Computed Tomography (CBCT)-Based Online Adaptive Radiotherapy for Patients With Metal Implants: An Institutional Experience.Cureus · Mar 1, 2026
Translating FLASH to the clinic: treatment planning system for a FLASH-compatible dose delivery using a novel x-ray UHDR machine.Physics in medicine and biology · Oct 17, 2025
Using deep learning generated CBCT contours for online dose assessment of prostate SABR treatments.Journal of applied clinical medical physics · Jun 1, 2025
Monte Carlo simulation of a novel medical linac concept for highly conformal x-ray FLASH cancer radiotherapy.Scientific reports · May 21, 2025
Investigation of hydrogen peroxide yields and oxygen consumption in high dose rate irradiation: a TOPAS-nBio Monte Carlo study.Physics in medicine and biology · Dec 24, 2024
Predicting the BRAF mutation with pretreatment MRI radiomics features for melanoma brain metastases receiving Gamma Knife radiosurgery.Clinical radiology · Dec 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
AutoContour (RADAC V5)K260509 · 510k · Mar 19, 2026
AutoContour (Model RADAC V4)K242729 · 510k · Dec 9, 2024
AutoContour Model RADAC V3K230685 · 510k · Apr 14, 2023
AutoContour Model RADAC V2K220598 · 510k · Aug 24, 2022
AutoContourK200323 · 510k · Oct 30, 2020
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Automated planning and evaluation tools
Automated checks and independent calculations
Automation of treatment planning workflow
Streamlined clinical workflow
Automated billing QA and workflow optimization
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Radformation
Recent articles published on Radformation's official website.
Research in Action: Abstract Highlights From AAPM | COMP 2026
Read on RadformationIntroducing OptiPlan: Automated VMAT Planning
Read on RadformationQuickCode’s Newest Capability Offers Added Protection Against Preventable Denials
Read on RadformationQuickCode’s Epic Integration Closes System Gaps to Improve Revenue Optimization and Compliance
Read on RadformationESTRO 2026 Research Highlights: Advancing Quality, Efficiency, and Access Through Automation
Read on Radformation07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.